← Back to Screener
Fractyl Health, Inc. Common Stock (GUTS)
Price$0.58
Favorite Metrics
Price vs S&P 500 (26W)-66.25%
Price vs S&P 500 (4W)19.62%
Market Capitalization$90.33M
All Metrics
Book Value / Share (Quarterly)$0.13
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.66
Price vs S&P 500 (YTD)-78.26%
Gross Margin (TTM)46.24%
Net Profit Margin (TTM)-73864.52%
EPS (TTM)$-2.27
10-Day Avg Trading Volume1.39M
EPS Excl Extra (TTM)$-2.27
EPS (Annual)$-1.58
ROI (Annual)-117.25%
Gross Margin (Annual)46.24%
Cash / Share (Quarterly)$0.59
ROA (Last FY)-63.56%
Revenue Growth TTM (YoY)-96.91%
EBITD / Share (TTM)$-2.24
Operating Margin (TTM)-100570.97%
Cash Flow / Share (Annual)$-1.38
P/B Ratio14.17x
P/B Ratio (Quarterly)9.13x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)467.18x
Net Interest Coverage (TTM)-2.97x
ROA (TTM)-133.04%
EPS Incl Extra (Annual)$-1.58
Current Ratio (Annual)3.63x
Quick Ratio (Quarterly)4.16x
3-Month Avg Trading Volume4.71M
52-Week Price Return-48.70%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)971.34x
Asset Turnover (Annual)0.00x
52-Week High$3.03
EPS Excl Extra (Annual)$-1.58
CapEx CAGR (5Y)78.65%
26-Week Price Return-57.51%
Quick Ratio (Annual)3.41x
13-Week Price Return-71.67%
Total Debt / Equity (Annual)1.06x
Current Ratio (Quarterly)4.27x
Enterprise Value$43.448
Asset Turnover (TTM)0.00x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-73864.52%
Cash / Share (Annual)$1.38
3-Month Return Std Dev160.84%
Net Income / Employee (TTM)$-1
ROE (Last FY)-241.68%
Net Interest Coverage (Annual)-28.26x
EPS Basic Excl Extra (Annual)$-1.58
Receivables Turnover (TTM)8.45x
Total Debt / Equity (Quarterly)4.61x
EPS Incl Extra (TTM)$-2.27
ROI (TTM)-130.03%
P/S Ratio (TTM)971.34x
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-83.80%
Year-to-Date Return-74.12%
5-Day Price Return16.20%
EPS Normalized (Annual)$-1.58
ROA (5Y Avg)-73.28%
Net Profit Margin (Annual)-73864.52%
Month-to-Date Return24.32%
EBITD / Share (Annual)$-1.72
Operating Margin (Annual)-100570.97%
LT Debt / Equity (Annual)1.06x
LT Debt / Equity (Quarterly)4.61x
EPS Basic Excl Extra (TTM)$-2.27
P/B Ratio (Annual)3.49x
Inventory Turnover (TTM)0.85x
Pretax Margin (TTM)-73864.52%
Book Value / Share (Annual)$0.58
Price vs S&P 500 (13W)-74.54%
Beta0.43x
Revenue / Share (TTM)$0.00
ROE (TTM)-228.66%
52-Week Low$0.38
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.27
4.18
4.18
4.18
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
GUTSFractyl Health, Inc. Common Stock | 971.34x | — | 46.24% | -100570.97% | $0.58 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Fractyl Health is a metabolic therapeutics company developing treatments for type 2 diabetes and obesity. The company targets organ-level root causes to deliver durable, disease-modifying therapies rather than chronic symptom management.